Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Chinese scientists develop Nav1.7 channel blockers

Nov. 21, 2016

Shanghai Fochon Pharmaceutical describes CDK4/cyclin D1 and CDK6/cyclin D1 inhibitors

Nov. 21, 2016

University of North Carolina at Chapel Hill discloses anticancer agents

Nov. 21, 2016

Omeros patents PDE10A inhibitors

Nov. 21, 2016

Sanford-Burnham Medical Research Institute presents EphA4 inhibitors

Nov. 18, 2016

Chinese researchers develop antiviral agents

Nov. 18, 2016

Janssen Pharmaceutica discloses TARPgamma8 modulators

Nov. 18, 2016

Eli Lilly and Company describes BACE1 inhibitors

Nov. 18, 2016

Sanford-Burnham Medical Research Institute patents APJ agonists

Nov. 18, 2016

Chinese scientists present FXR agonists

Nov. 17, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...